Thomas G. Boyer - Publications

The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States 
Molecular Biology

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Park MJ, Shen H, Kim NH, Gao F, Failor C, Knudtson JF, McLaughlin J, Halder SK, Heikkinen TA, Vahteristo P, Al-Hendy A, Schenken RS, Boyer TG. Mediator kinase disruption in MED12-mutant uterine fibroids from Hispanic women of South Texas. The Journal of Clinical Endocrinology and Metabolism. PMID 30099503 DOI: 10.1210/jc.2018-00863  0.6
2018 Park MJ, Shen H, Spaeth JM, Tolvanen JH, Failor C, Knudtson JF, McLaughlin J, Halder SK, Yang Q, Bulun SE, Al-Hendy A, Schenken RS, Aaltonen LA, Boyer TG. Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of Cyclin C-CDK8/19. The Journal of Biological Chemistry. PMID 29440396 DOI: 10.1074/jbc.RA118.001725  0.6
2016 Kim NH, Livi CB, Yew PR, Boyer TG. Mediator subunit Med12 contributes to the maintenance of neural stem cell identity. Bmc Developmental Biology. 16: 17. PMID 27188461 DOI: 10.1186/s12861-016-0114-0  0.68
2015 Wang L, Zeng H, Wang Q, Zhao Z, Boyer TG, Bian X, Xu W. MED12 methylation by CARM1 sensitizes human breast cancer cells to chemotherapy drugs. Science Advances. 1: e1500463. PMID 26601288 DOI: 10.1126/sciadv.1500463  0.32
2015 Kämpjärvi K, Kim NH, Keskitalo S, Clark AD, von Nandelstadh P, Turunen M, Heikkinen T, Park MJ, Mäkinen N, Kivinummi K, Lintula S, Hotakainen K, Nevanlinna H, Hokland P, Böhling T, ... ... Boyer TG, et al. Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms. The Prostate. PMID 26383637 DOI: 10.1002/pros.23092  0.68
2015 Clark AD, Oldenbroek M, Boyer TG. Mediator kinase module and human tumorigenesis. Critical Reviews in Biochemistry and Molecular Biology. 1-34. PMID 26182352 DOI: 10.3109/10409238.2015.1064854  0.68
2014 Kämpjärvi K, Park MJ, Mehine M, Kim NH, Clark AD, Bützow R, Böhling T, Böhm J, Mecklin JP, Järvinen H, Tomlinson IP, van der Spuy ZM, Sjöberg J, Boyer TG, Vahteristo P. Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas. Human Mutation. 35: 1136-41. PMID 24980722 DOI: 10.1002/humu.22612  0.68
2014 Turunen M, Spaeth JM, Keskitalo S, Park MJ, Kivioja T, Clark AD, Mäkinen N, Gao F, Palin K, Nurkkala H, Vähärautio A, Aavikko M, Kämpjärvi K, Vahteristo P, Kim CA, ... ... Boyer TG, et al. Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity. Cell Reports. 7: 654-60. PMID 24746821 DOI: 10.1016/j.celrep.2014.03.047  0.68
2013 Vulto-van Silfhout AT, de Vries BB, van Bon BW, Hoischen A, Ruiterkamp-Versteeg M, Gilissen C, Gao F, van Zwam M, Harteveld CL, van Essen AJ, Hamel BC, Kleefstra T, Willemsen MA, Yntema HG, van Bokhoven H, ... ... Boyer TG, et al. Mutations in MED12 cause X-linked Ohdo syndrome. American Journal of Human Genetics. 92: 401-6. PMID 23395478 DOI: 10.1016/j.ajhg.2013.01.007  0.68
2012 Zhou H, Spaeth JM, Kim NH, Xu X, Friez MJ, Schwartz CE, Boyer TG. MED12 mutations link intellectual disability syndromes with dysregulated GLI3-dependent Sonic Hedgehog signaling. Proceedings of the National Academy of Sciences of the United States of America. 109: 19763-8. PMID 23091001 DOI: 10.1073/pnas.1121120109  0.68
2012 Gu S, Boyer TG, Naski MC. Basic helix-loop-helix transcription factor Twist1 inhibits transactivator function of master chondrogenic regulator Sox9. The Journal of Biological Chemistry. 287: 21082-92. PMID 22532563 DOI: 10.1074/jbc.M111.328567  0.68
2011 Krebs P, Fan W, Chen YH, Tobita K, Downes MR, Wood MR, Sun L, Li X, Xia Y, Ding N, Spaeth JM, Moresco EM, Boyer TG, Lo CW, Yen J, et al. Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet. Proceedings of the National Academy of Sciences of the United States of America. 108: 19678-82. PMID 22106289 DOI: 10.1073/pnas.1117835108  0.68
2011 Spaeth JM, Kim NH, Boyer TG. Mediator and human disease. Seminars in Cell & Developmental Biology. 22: 776-87. PMID 21840410 DOI: 10.1016/j.semcdb.2011.07.024  0.68
2011 Xu X, Zhou H, Boyer TG. Mediator is a transducer of amyloid-precursor-protein-dependent nuclear signalling. Embo Reports. 12: 216-22. PMID 21293490 DOI: 10.1038/embor.2010.210  0.68
2009 Ding N, Tomomori-Sato C, Sato S, Conaway RC, Conaway JW, Boyer TG. MED19 and MED26 are synergistic functional targets of the RE1 silencing transcription factor in epigenetic silencing of neuronal gene expression. The Journal of Biological Chemistry. 284: 2648-56. PMID 19049968 DOI: 10.1074/jbc.M806514200  0.68
2008 Ding N, Zhou H, Esteve PO, Chin HG, Kim S, Xu X, Joseph SM, Friez MJ, Schwartz CE, Pradhan S, Boyer TG. Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation. Molecular Cell. 31: 347-59. PMID 18691967 DOI: 10.1016/j.molcel.2008.05.023  0.68
2006 Zhou H, Kim S, Ishii S, Boyer TG. Mediator modulates Gli3-dependent Sonic hedgehog signaling. Molecular and Cellular Biology. 26: 8667-82. PMID 17000779 DOI: 10.1128/MCB.00443-06  0.68
2006 Kim S, Xu X, Hecht A, Boyer TG. Mediator is a transducer of Wnt/beta-catenin signaling. The Journal of Biological Chemistry. 281: 14066-75. PMID 16565090 DOI: 10.1074/jbc.M602696200  0.68
2004 Tan W, Zheng L, Lee WH, Boyer TG. Functional dissection of transcription factor ZBRK1 reveals zinc fingers with dual roles in DNA-binding and BRCA1-dependent transcriptional repression. The Journal of Biological Chemistry. 279: 6576-87. PMID 14660588 DOI: 10.1074/jbc.M312270200  0.4
2002 Zhong Q, Boyer TG, Chen PL, Lee WH. Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. Cancer Research. 62: 3966-70. PMID 12124328  0.4
Show low-probability matches.